Related Experiment Video
Updated: Dec 4, 2025

18:48
In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients
Published on: August 12, 2017
14.7K
Imlifidase Shows Promise for the Most Disadvantaged Sensitized Transplant Candidates
1William J. von Liebig Center for Transplantation and Clinical Regeneration, Department of Internal Medicine, Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN.
Transplantation
|October 23, 2020
Abstract
No abstract available in PubMed .

